Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD)
CUSIP: 00534A102
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, $0.0001 par value per share
- Shares outstanding
- 291,486,949
- Total 13F shares
- 60,449,568
- Share change
- -9,976,661
- Total reported value
- $43,221,357
- Put/Call ratio
- 0%
- Price per share
- $0.72
- Number of holders
- 65
- Value change
- -$6,829,936
- Number of buys
- 28
- Number of sells
- 54
Quarterly Holders Quick Answers
What is CUSIP 00534A102?
CUSIP 00534A102 identifies IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 00534A102:
Top shareholders of IVVD - Invivyd, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Adimab, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
21,687,906
|
$85,667,229 | — | 19 Jan 2024 | |
| MITHRIL II LP |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
11,241,580
|
$44,404,241 | — | 28 Mar 2022 | |
| Redmile Group, LLC |
3/4/5
13F
|
10%+ Owner · Company |
0.78%
from 13F
|
3,390,960
|
$13,394,292 | — | 10 Aug 2021 | |
| Rene Russo |
3/4/5
|
Director |
—
mixed-class rows
|
2,020,888
mixed-class rows
|
$7,841,915 | — | 05 Aug 2021 | |
| Mithril II GP LP |
13F
|
Company |
3.9%
|
11,241,580
|
$6,804,528 | — | 31 Mar 2025 | |
| MAVERICK CAPITAL LTD |
13F
|
Company |
3.8%
|
10,958,572
|
$6,633,224 | — | 31 Mar 2025 | |
| Deep Track Capital, LP |
13F
|
Company |
3.3%
|
9,722,254
|
$5,884,880 | — | 31 Mar 2025 | |
| M28 Capital Management LP |
13F
|
Company |
3.2%
|
9,248,250
|
$5,597,966 | — | 31 Mar 2025 | |
| Ajay Royan |
3/4/5
|
Director |
—
mixed-class rows
|
11,249,799
mixed-class rows
|
$5,008,124 | — | 20 May 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
4.8%
|
5,775,549
|
$3,811,862 | $0 | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
|
Company |
1.8%
|
5,349,314
|
$3,237,940 | — | 31 Mar 2025 | |
| Cox Christopher T. |
3/4/5
|
Other* |
—
class O/S missing
|
679,822
|
$2,685,297 | — | 28 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.5%
|
4,396,990
|
$2,660,179 | — | 31 Mar 2025 | |
| Polaris Venture Partners V, L.P. |
3/4/5
|
Other* |
—
class O/S missing
|
497,660
|
$1,965,757 | — | 28 Mar 2022 | |
| 683 Capital Management, LLC |
13F
|
Company |
1%
|
3,000,000
|
$1,815,900 | — | 31 Mar 2025 | |
| Terrance McGuire |
3/4/5
|
Director |
—
mixed-class rows
|
3,116,757
mixed-class rows
|
$1,366,240 | — | 20 May 2025 | |
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
0.62%
|
1,799,595
|
$1,089,295 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.56%
|
1,625,654
|
$984,114 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.34%
|
997,133
|
$603,565 | — | 31 Mar 2025 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.32%
|
933,500
|
$565,048 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.25%
|
741,122
|
$448,601 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.22%
|
655,278
|
$399,720 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
589,034
|
$356,542 | — | 31 Mar 2025 | |
| Duquesne Family Office LLC |
13F
|
Company |
0.2%
|
571,425
|
$346,000 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.15%
|
440,694
|
$266,620 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
410,711
|
$248,603 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.14%
|
400,000
|
$242,120 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.09%
|
260,686
|
$157,793 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.09%
|
255,970
|
$154,939 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.08%
|
240,607
|
$145,639 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
192,660
|
$117,000 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.06%
|
186,680
|
$112,997 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.06%
|
161,275
|
$97,620 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.04%
|
113,115
|
$68,469 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.04%
|
109,130
|
$66,056 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.04%
|
108,999
|
$65,978 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.04%
|
107,119
|
$64,839 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
100,240
|
$60,675 | — | 31 Mar 2025 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.03%
|
96,507
|
$58,869 | — | 31 Mar 2025 | |
| a16z Perennial Management, L.P. |
13F
|
Company |
0.03%
|
79,869
|
$48,345 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
78,845
|
$48,000 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
79,133
|
$47,871 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
71,213
|
$43,105 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.02%
|
64,570
|
$39,000 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
57,661
|
$34,903 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.02%
|
48,309
|
$29,241 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
47,852
|
$28,964 | — | 31 Mar 2025 | |
| Cerity Partners LLC |
13F
|
Company |
0.01%
|
39,293
|
$23,784 | — | 31 Mar 2025 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.01%
|
39,266
|
$23,768 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
39,237
|
$23,738 | — | 31 Mar 2025 |
Institutional Holders of Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) as of Q2 2025
As of 30 Jun 2025,
Invivyd, Inc. - Common Stock, $0.0001 par value per share (IVVD) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
60,449,568 shares.
The largest 10 holders included
Mithril II GP LP, MAVERICK CAPITAL LTD, M28 Capital Management LP, Deep Track Capital, LP, VANGUARD GROUP INC, 683 Capital Management, LLC, Redmile Group, LLC, Bain Capital Life Sciences Investors, LLC, BlackRock, Inc., and MILLENNIUM MANAGEMENT LLC.
This page lists
65
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
80
Q2 2025 holders
65
Holder diff
-15
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.